The FDA Just Rewrote the Rules for Gene Therapy Approval & Most Investors Haven't Noticed Yet: The Plausible Mechanism Framework and NGS Safety Guidance That Could Reshape Rare Disease Investment

Thoughts on Healthcare Markets & Technology Podcast

0:00

-20:21

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

The FDA Just Rewrote the Rules for Gene Therapy Approval & Most Investors Haven't Noticed Yet: The Plausible Mechanism Framework and NGS Safety Guidance That Could Reshape Rare Disease Investment

Two FDA draft guidances published in early 2026 represent the most significant gene therapy regulatory shift in over two decades.

May 04, 2026

∙ Paid

Quick Links: Knowledge Base, Podcast, and Social

Knowledge Base — search and filter every article and podcast episode by topic, section, and keyword: kb.onhealthcare.tech

Listen to the Podcast — every article is also available as an audio episode. Free subscribers get the public episodes; paid subscribers get the full archive including subscriber-only epi…

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.